Skip to main content
TipRanks
Go Ultimate75% OFF

BioNeutra Global (BGA) Stock Statistics & Valuation Metrics

113 Followers

Total Valuation

BioNeutra Global has a market cap or net worth of CAD 1.39M. The enterprise value is CAD 6.91T.

Market Cap
CAD 1.39M
Enterprise Value
CAD 6.91T

Share Statistics

BioNeutra Global has 46,448,788 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
46,448,788
Owned by Insiders
―
Owned by Institutions
―

Financial Efficiency

BioNeutra Global’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

Return on Equity (ROE)
―
Return on Assets (ROA)
―
Return on Invested Capital (ROIC)
―
Return on Capital Employed (ROCE)
―
Revenue Per Employee
―
Profits Per Employee
―
Employee Count
0
Asset Turnover
―
Inventory Turnover
―

Income Statement

In the last 12 months, BioNeutra Global had revenue of ― and earned 1.08M in profits. Earnings per share was ―.

Revenue
―
Gross Profit
9.22M
Operating Income
2.72M
Pretax Income
―
Net Income
1.08M
EBITDA
3.81M
Earnings Per Share (EPS)
―

Stock Price Statistics

Beta
1.36
52-Week Price Change
0.00%
50-Day Moving Average
0.03
200-Day Moving Average
0.03
Relative Strength Index (RSI)
―
Average Volume (3m)
―

Important Dates

BioNeutra Global upcoming earnings date is ―, TBA (Not Confirmed).

Last Earnings Date
Aug 27, 2025
Next Earnings Date
―
Ex-Dividend Date
―

Balance Sheet

BioNeutra Global has ― in cash and marketable securities with CAD 7.19M in debt, giving a net cash position of ― billion.

Cash & Marketable Securities
―
Total Debt
CAD 7.19M
Net Cash
―
Net Cash Per Share
―
Tangible Book Value Per Share
―

Analyst Forecast

The average price target for BioNeutra Global is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
0
Revenue Growth Forecast
―
EPS Growth Forecast
―